tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
NASDAQ:CYTK

Compare Cytokinetics (CYTK) vs. Competitors

Compare
1,235 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cytokinetics
$63.44
$7.90B
-10.05
35.34%
15 Buy
2 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$174.14
$8.92B
-37.26
85.75%
14 Buy
1 Hold
0 Sell
Strong Buy
Rhythm Pharmaceuticals
$106.06
$7.56B
-34.18
97.65%
14 Buy
1 Hold
0 Sell
Strong Buy
Legend Biotech
$22.11
$4.30B
-16.93
-29.88%
10 Buy
1 Hold
0 Sell
Strong Buy
Avidity Biosciences
$72.60
$10.94B
-17.41
160.50%
2 Buy
11 Hold
0 Sell
Hold
Nuvalent
$106.16
$7.84B
-19.97
37.09%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CYTK
Cytokinetics
63.44
17.70
38.69%
AXSM
Axsome Therapeutics
174.14
82.20
89.41%
RYTM
Rhythm Pharmaceuticals
106.06
51.52
94.46%
LEGN
Legend Biotech
22.11
-10.55
-32.30%
RNA
Avidity Biosciences
72.60
43.68
151.04%
NUVL
Nuvalent
106.16
30.32
39.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts